TechExpo X Keynote "Imagining the Role of Universities in the New Information Era"


Robert M. Califf, M.D., M.A.C.C., and the Donald F. Fortin, M.D., Professor of Cardiology at Duke University School of Medicine

Speaker:

Robert M. Califf, M.D., M.A.C.C., and the Donald F. Fortin, M.D., Professor of Cardiology at Duke University School of Medicine

Biography:

Dr. Califf was Food and Drug Administration (FDA) Deputy Commissioner for Medical Products and Tobacco from February 2015 until his appointment as Commissioner of the FDA in February 2016.

Prior to joining the FDA, Dr. Califf was a professor of medicine and vice chancellor for clinical and translational research at Duke University. He also served as director of the Duke Translational Medicine Institute, and he was the founding director of the Duke Clinical Research Institute. A nationally and internationally recognized expert in cardiovascular medicine, health outcomes research, healthcare quality, and clinical research, Dr. Califf has led many landmark clinical trials and is one of the most frequently cited authors in biomedical science, with more than 1,200 publications in the peer-reviewed literature.

Dr. Califf is a member of the National Academy of Medicine, formerly known as the Institute of Medicine (IOM), one of the highest honors in the fields of health and medicine, in 2016. He has served on numerous IOM committees, and he has served as a member of the FDA Cardiorenal Advisory Panel and FDA Science Board’s Subcommittee on Science and Technology. Dr. Califf has also served on the Board of Scientific Counselors for the National Library of Medicine, as well as on advisory committees for the National Cancer Institute, the National Heart, Lung, and Blood Institute, the National Institute of Environmental Health Sciences and the Council of the National Institute on Aging. He has led major initiatives aimed at improving methods and infrastructure for clinical research, including the Clinical Trials Transformation Initiative (CTTI), a public-private partnership co-founded by the FDA and Duke. He also served as the principal investigator for Duke's Clinical and Translational Science Award and the NIH Health Care Systems Research Collaboratory, and co-principal investigator of the Patient Centered Outcomes Research Institute Network.